Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventDec 23, 2002View HTMLDownload DOCDownload PDF
S-3Simplified registration formDec 20, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 26, 2002View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionNov 12, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 1, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 30, 2002View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KOct 18, 2002View HTMLDownload DOCDownload PDFDownload XLS
POS AMPost-effective amendment to an S-Type filingOct 3, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventSep 30, 2002View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 17, 2002View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 13, 2002View HTMLDownload DOCDownload PDF
424B3Form of prospectus reflecting facts events constituting substantive change from last formSep 13, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-A12GRegistration of certain classes of securities 12(g) of the Securities Exchange ActSep 13, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 26, 2002View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionAug 14, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 2, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventAug 1, 2002View HTMLDownload DOCDownload PDF
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Jul 31, 2002View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJul 29, 2002View HTMLDownload DOCDownload PDF
S-3/APre-effective amendment to an S-3 filingJul 26, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJul 15, 2002View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJul 9, 2002View HTMLDownload DOCDownload PDF
DEFM14AOfficial notification of matters relating to a merger or acquisitionJul 5, 2002View HTMLDownload DOCDownload PDFDownload XLS
S-3/APre-effective amendment to an S-3 filingJul 5, 2002View HTMLDownload DOCDownload PDFDownload XLS
PRER14AProxy soliciting materials. Revised preliminary materialJun 25, 2002View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-48

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information